Sg Americas Securities, LLC Sarepta Therapeutics, Inc. Transaction History
Sg Americas Securities, LLC
- $27.6 Billion
- Q3 2024
A detailed history of Sg Americas Securities, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,193 shares of SRPT stock, worth $936,456. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,193
Previous 12,062
40.37%
Holding current value
$936,456
Previous $1.91 Million
52.89%
% of portfolio
0.0%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding SRPT
# of Institutions
557Shares Held
85.8MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.34 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.18 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$563 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$539 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$497 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...